Mike Dombeck leads business development at Precision BioSciences. Prior to joining Precision, Mike was a Director in GlaxoSmithKline’s R&D Strategy and Portfolio Management group. Mike has nearly 20 years of industry experience, spanning market research and portfolio planning with Talecris, business development for DarPharma, Inc., business development and corporate strategy consulting with Campbell Alliance, and as a co-founder of Cempra Pharmaceuticals. When he’s not deal-making, Mike enjoys coaching his daughters’ soccer teams, learning slow-cooking techniques, and exploring the world through a camera lens. Mike completed both his undergraduate and graduate studies at Duke University, with an MBA and Master of Public Policy, and a B.S. in biology and health policy.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.